Tornier (NAS: TRNX) reported earnings on May 8. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended April 1 (Q1), Tornier met expectations on revenues and missed expectations on earnings per share.
Compared to the prior-year quarter, revenue increased and GAAP earnings per share expanded to zero.
Margins increased across the board.
Tornier booked revenue of $74.5 million. The nine analysts polled by S&P Capital IQ anticipated revenue of $75.0 million on the same basis. GAAP reported sales were 7.2% higher than the prior-year quarter's $69.4 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.00. The five earnings estimates compiled by S&P Capital IQ predicted $0.01 per share. GAAP EPS contracted to zero from the prior-year quarter's -$0.68.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 71.6%, 50 basis points better than the prior-year quarter. Operating margin was 1.7%, 60 basis points better than the prior-year quarter. Net margin was -0.2%, 3,430 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $69.5 million. On the bottom line, the average EPS estimate is -$0.01.
Next year's average estimate for revenue is $281.5 million. The average EPS estimate is $0.01.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 11 members out of 14 rating the stock outperform, and three members rating it underperform. Among four CAPS All-Star picks (recommendations by the highest-ranked CAPS members), two give Tornier a green thumbs-up, and two give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Tornier is outperform, with an average price target of $26.88.
The healthcare investing landscape is littered with also-rans and a few major winners. Is Tornier the right stock for you? Read "Discover the Next Rule-Breaking Multibagger" to learn about a company David Gardner believes will be a phenomenal success over the next few years. Click here for instant access to this free report.
Add Tornier to My Watchlist.
At the time thisarticle was published Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.